Intracorneal injection of a detachable hybrid microneedle for sustained drug delivery

Acta Biomaterialia - Tập 80 - Trang 48-57 - 2018
KangJu Lee1, Hyun Beom Song2,3, Wonwoo Cho1, Jin Hyoung Kim3, Jeong Hun Kim3,4,5, WonHyoung Ryu1
1Department of Mechanical Engineering, Yonsei University, Seoul 03722, Republic of Korea
2Department of Parasitology and Tropical Medicine, Institute of Endemic Diseases, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
3Fight against Angiogenesis, Related Blindness Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul 03080, Republic of Korea
4Department of Biomedical Sciences, Seoul National University Graduate School, Seoul 03080, Republic of Korea
5Department of Ophthalmology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea

Tài liệu tham khảo

Pierre, 2014, Microneedle-based drug delivery systems for transdermal route, Curr. Drug Targets, 15, 281, 10.2174/13894501113146660232 Donnelly, 2010, Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety, Drug Delivery, 17, 187, 10.3109/10717541003667798 Bloomfield, 1978, Soluble gentamicin ophthalmic inserts as a drug delivery system, Arch. Ophthamol., 96, 885, 10.1001/archopht.1978.03910050487020 Sasaki, 2003, One-side-coated insert as a unique ophthalmic drug delivery system, J. Control. Release, 92, 241, 10.1016/S0168-3659(03)00362-6 Lamberts, 1978, A clinical study of slow-releasing artificial tears, Ophthalmology, 85, 794, 10.1016/S0161-6420(78)35610-4 Gurtler, 1995, Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation, J. Control. Release, 33, 231, 10.1016/0168-3659(94)00096-D Chetonia, 1998, Silicone rubber/hydrogel composite ophthalmic inserts: preparation and preliminary in vitro/in vivo evaluation, Eur. J. Pharm. Biopharm., 46, 125, 10.1016/S0939-6411(97)00168-9 Stephane, 2006, Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: potential alternative as drug delivery system prior to cataract surgery, Basic Clin. Pharmacol., 98, 547, 10.1111/j.1742-7843.2006.pto_362.x Pijls, 2007, Pradofloxacin release from the OphthaCoil: a new device for sustained delivery of drugs to the eye, J. Drug Deliv. Sci. Tec., 17, 87, 10.1016/S1773-2247(07)50012-2 Maulvi, 2016, In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery, J. Control. Release, 226, 47, 10.1016/j.jconrel.2016.02.012 Carvalho, 2015, Sustained drug release by contact lenses for glaucoma treatment-a review, J. Control. Release, 202, 76, 10.1016/j.jconrel.2015.01.023 Tieppo, 2012, Sustained in vivo release from imprinted therapeutic contact lenses, J. Control. Release, 157, 391, 10.1016/j.jconrel.2011.09.087 Ali, 2007, Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow, J. Control. Release, 124, 154, 10.1016/j.jconrel.2007.09.006 Järvinen, 1995, Ocular absorption following topical delivery, Adv. Drug Deliver. Rev., 16, 3, 10.1016/0169-409X(95)00010-5 Jiang, 2007, Coated microneedles for drug delivery to the eye, Invest. Ophthalmol. Vis. Sci., 48, 4038, 10.1167/iovs.07-0066 Khandan, 2016, Fenestrated microneedles for ocular drug delivery, Sensor. Actuat. B-CHEM., 223, 15, 10.1016/j.snb.2015.09.071 Prausnitz, 2014, Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization, Invest. Ophthalmol. Vis. Sci., 55, 7376, 10.1167/iovs.14-15257 Song, 2015, Impact insertion of transfer-molded microneedle for localized and minimally invasive ocular drug delivery, J. Control. Release, 209, 272, 10.1016/j.jconrel.2015.04.041 Holden, 1985, Effects of long-term extended contact lens wear on the human cornea, Invest. Ophthalmol. Vis. Sci, 26, 1489 Bhatnagar, 2017, Corneal delivery of besifloxacin using rapidly dissolving polymeric microneedles, Drug Deliv. Transl. Re., 1 Jensen, 1970, Axenic cultivation of large populations of Acanthamoeba castellanii (JBM), J. Parasitol., 904, 10.2307/3277503 Suryawanshi, 2015, IL-17A-mediated protection against Acanthamoeba Keratitis, J. Immunol., 194, 650, 10.4049/jimmunol.1302707 Ren, 2010, Evaluation of three different methods to establish animal models of Acanthamoeba keratitis, Yonsei Med. J., 51, 121, 10.3349/ymj.2010.51.1.121 Ge, 2013, Rapid and sensitive diagnosis of Acanthamoeba keratitis by loop-mediated isothermal amplification, Clin. Microbiol. Infect., 19, 1042, 10.1111/1469-0691.12149 Dai, 2005, A quantitative study on the adhesion property of cured SU-8 on various metallic surfaces, Microsyst. Technol., 11, 526, 10.1007/s00542-005-0587-4 Lee, 2007, Cysticidal effect on Acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine, Cornea, 26, 736, 10.1097/ICO.0b013e31805b7e8e Kunou, 2000, Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis, J. Control. Release, 68, 263, 10.1016/S0168-3659(00)00267-4 Chu, 2011, Separable arrowhead microneedles, J. Control. Release, 149, 242, 10.1016/j.jconrel.2010.10.033 Yu, 2017, Near-infrared light triggered and separable microneedles for transdermal delivery of metformin in diabetic rats, J. Mater. Chem. B, 5, 9507, 10.1039/C7TB02236K Hsu, 2013, Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses, Eur. J. Pharm. Biopharm., 85, 531, 10.1016/j.ejpb.2013.04.017